Table 2.
Correlation of tumor integrin α7 expression with tumor characteristics
| Characteristics | Tumor integrin α7 expression | P value | |
|---|---|---|---|
| High | Low | ||
| Tumor location | .333 | ||
| Right (n/%) | 30 (34.9) | 56 (65.1) | |
| Left (n/%) | 39 (41.9) | 54 (58.1) | |
| Pathological Grade | .004 | ||
| 1 (n/%) | 24 (30.4) | 55 (69.6) | |
| 2 (n/%) | 29 (37.2) | 49 (62.8) | |
| 3 (n/%) | 16 (72.7) | 6 (27.3) | |
| Tumor size | .107 | ||
| ≤5 cm (n/%) | 31 (33.0) | 63 (67.0) | |
| >5 cm (n/%) | 38 (44.7) | 47 (55.3) | |
| T stage | .017 | ||
| T1 (n/%) | 44 (33.6) | 87 (66.4) | |
| T2 (n/%) | 18 (47.4) | 20 (52.6) | |
| T3 (n/%) | 7 (70.0) | 3 (30.0) | |
| N stage | .146 | ||
| N0 (n/%) | 62 (37.1) | 105 (62.9) | |
| N1 (n/%) | 7 (58.3) | 5 (41.7) | |
| TNM stage | .033 | ||
| I (n/%) | 42 (33.6) | 83 (66.4) | |
| II (n/%) | 17 (47.2) | 19 (52.8) | |
| III (n/%) | 10 (55.6) | 8 (44.4) | |
Data were presented as count (percentage). Comparison was determined by Chi‐square test or Wilcoxon rank sum test. P value < .05 was considered significant (in bold). Pathological grade 1: well differentiated; Pathological grade 2: moderately differentiated; Pathological grade 3: poorly differentiated.